US EditionFDA-Cleared Hydrogel Device for Wound Healing Enters Commercial Production
Summary by Plastic Surgery Practice
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
FDA-Cleared Hydrogel Device for Wound Healing Enters Commercial Production
The collagen-based dermal regeneration template is designed for improved patient outcomes in the treatment of full-thickness wounds. FesariusTherapeutics Inc, a commercial-stage bioregenerative surgical company focused on delivering solutions for the wound care, reconstructive surgery, and regenerative medicine markets, announced it entered into a manufacturing and supply agreement with Regenity Bioscience to provide Regenity exclusive manufactu…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
